| Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis. | |
| | |
MedLine Citation:
|
PMID: 18528965 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To investigate whether statins may improve endothelial function in systemic sclerosis (SSc) by evaluating the effects of simvastatin on vasculogenesis [indicated by the expansion of circulating endothelial progenitor cells (EPC)] and the markers of vascular injury in the peripheral blood of patients with SSc. METHODS: Twenty SSc patients with normal cholesterol concentrations and 20 hypercholesterolemic subjects were allocated to receive 20 mg/day simvastatin for 12 weeks. Peripheral blood samples were collected before and 12 weeks after initiation of treatment, and 4 weeks after discontinuation. Five-parameter, 3-color flow cytometry was performed with a FacScan to enumerate EPC and mature circulating endothelial cells (CEC). Levels of soluble E-selectin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, interleukin 6, and endothelin-1 were assessed by commercial ELISA. RESULTS: Simvastatin treatment significantly increased EPC in the hypercholesterolemic group, but failed to improve the EPC levels in the SSc patients, mainly in patients with late disease. Baseline levels of CEC were significantly higher in SSc patients compared with controls and at the end of the treatment they were significantly decreased. Regarding other markers of endothelial activation, we found that all the cytokine levels decreased in a statistically significant manner in the treated patients. CONCLUSION: Treatment with simvastatin results in rapid and significant improvement of measures of endothelial activation, suggesting a potential role of statins in the treatment of peripheral vascular disease in SSc. The lack of effect on increase of EPC confirms our previous findings of a defective endothelial stem cell recruitment in the bone marrow of SSc patients. This could indicate that the potential effectiveness of statins in SSc could mainly be ascribed to their effectiveness in modulating endothelial activation mechanisms. |
| | |
Authors:
|
Nicoletta Del Papa; Michela Cortiana; Claudio Vitali; Ilaria Silvestris; Wanda Maglione; Denise P Comina; Tiziano Lucchi; Agostino Cortelezzi |
Related Documents
:
|
17510705 - Psgl-1-mediated activation of ephb4 increases the proangiogenic potential of endothelia... 16411405 - Presence of endothelial progenitor cells, distinct from mature endothelial cells, withi... 15313945 - Integrin profile and in vivo homing of human smooth muscle progenitor cells. 19538255 - T17b murine embryonal endothelial progenitor cells can be induced towards both prolifer... 23733875 - Cyclooxygenase-2 deficiency in macrophages leads to defective p110γ pi3k signaling and... 21757895 - Vdr expression on circulating endothelial progenitor cells in dialysis patients is modu... |
Publication Detail:
|
Type: Clinical Trial; Journal Article Date: 2008-06-01 |
Journal Detail:
|
Title: The Journal of rheumatology Volume: 35 ISSN: 0315-162X ISO Abbreviation: J. Rheumatol. Publication Date: 2008 Jul |
Date Detail:
|
Created Date: 2008-07-08 Completed Date: 2008-12-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7501984 Medline TA: J Rheumatol Country: Canada |
Other Details:
|
Languages: eng Pagination: 1323-8 Citation Subset: IM |
Affiliation:
|
Department of Rheumatology, G. Pini Hospital, Milano, Italy. delpapa@gpini.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Case-Control Studies Endothelial Cells / cytology, drug effects Female Flow Cytometry Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use* Hypercholesterolemia / drug therapy Middle Aged Scleroderma, Systemic / drug therapy* Simvastatin / therapeutic use* Stem Cells / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 79902-63-9/Simvastatin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Psoriatic arthritis quality of life instrument: an assessment of sensitivity and response to change.
Next Document: N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: relationship with inflamma...